|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
ES2096590T3
(es)
|
1989-06-29 |
1997-03-16 |
Medarex Inc |
Reactivos biespecificos para la terapia del sida.
|
|
US5670617A
(en)
|
1989-12-21 |
1997-09-23 |
Biogen Inc |
Nucleic acid conjugates of tat-derived transport polypeptides
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
EP1690934A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
ATE300615T1
(de)
|
1990-08-29 |
2005-08-15 |
Genpharm Int |
Transgene mäuse fähig zur produktion heterologer antikörper
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
EP0586505A1
(en)
|
1991-05-14 |
1994-03-16 |
Repligen Corporation |
Heteroconjugate antibodies for treatment of hiv infection
|
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
|
NZ255101A
(en)
|
1992-07-24 |
1997-08-22 |
Cell Genesys Inc |
A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
|
|
MD1367C2
(ro)
|
1992-11-13 |
2000-11-30 |
Idec Pharmaceuticals Corporation |
Metode de tratament al limfomului celulelor B, anticorpi anti-CD20, hibridom.
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
|
BR9610058A
(pt)
|
1995-07-28 |
1999-07-27 |
Marie Curie Cancer Care |
Uso de vp22 ou uma porção ativa fragmento ou homólogo do mesmo proteína de transporte ácido nucleíco vetor de expressão célula hospedeira de mamíferos ou microbiana e processos para transportar uma proteína ou peptídeo desejado para uma população de marcaç o de células e para transportar uma molécula desejada em uma população de células
|
|
EP0799422A1
(en)
|
1995-10-24 |
1997-10-08 |
Sangstat Medical Corporation |
Anti alpha-galactosyl screening technique
|
|
US5965703A
(en)
|
1996-09-20 |
1999-10-12 |
Idun Pharmaceuticals |
Human bad polypeptides, encoding nucleic acids and methods of use
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
WO1999014321A1
(en)
|
1997-09-17 |
1999-03-25 |
The Walter And Eliza Hall Institute Of Medical Research |
Novel therapeutic molecules
|
|
US20020029391A1
(en)
|
1998-04-15 |
2002-03-07 |
Claude Geoffrey Davis |
Epitope-driven human antibody production and gene expression profiling
|
|
WO2000059526A1
(en)
|
1999-04-07 |
2000-10-12 |
Thomas Jefferson University |
Enhancement of peptide cellular uptake
|
|
AU6906100A
(en)
|
1999-08-16 |
2001-03-13 |
Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The |
Receptor-mediated uptake of an extracellular bcl-xl fusion protein inhibits apoptosis
|
|
WO2002020568A2
(en)
|
2000-09-06 |
2002-03-14 |
Abbott Laboratories |
Mutant peptides derived from bad and their use to identify substances which bind to a member of the bcl-2 family of proteins
|
|
WO2002069995A2
(en)
|
2001-02-16 |
2002-09-12 |
Medical College Of Georgia Research Institute, Inc. |
Use of trail and antiprogestins for treating cancer
|
|
WO2003040168A2
(en)
|
2001-11-06 |
2003-05-15 |
Enanta Pharmaceuticals, Inc. |
Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
|
|
WO2003055515A1
(en)
|
2001-12-21 |
2003-07-10 |
Arius Research, Inc. |
Individualized anti-cancer antibodies
|
|
WO2004022580A2
(en)
|
2002-09-09 |
2004-03-18 |
Dana-Farber Cancer Institute, Inc. |
Bh3 peptides and method of use thereof
|
|
WO2004058804A1
(en)
|
2002-12-24 |
2004-07-15 |
Walter And Eliza Hall Institute Of Medical Research |
Peptides and therapeutic uses thereof
|
|
EP1608969A4
(en)
|
2003-03-19 |
2007-06-06 |
Alfa Wassermann Inc |
SEPARATION AND ACCUMULATION OF SUB-CELLULAR COMPONENTS, AND PROTEINS WHICH ARE DRAWN THEREFROM
|
|
EP1997828B1
(en)
|
2003-11-05 |
2017-10-04 |
Dana-Farber Cancer Institute, Inc. |
Stabilized alpha helical peptides from BCL-2 and uses thereof
|
|
US7714005B2
(en)
|
2004-12-22 |
2010-05-11 |
The Ohio State University Research Foundation |
Small molecule Bcl-xL/Bcl-2 binding inhibitors
|
|
JP2005130867A
(ja)
|
2005-02-16 |
2005-05-26 |
Mitokor |
ミトコンドリア内カルシウムを使用するスクリーニングアッセイ
|
|
WO2006099667A1
(en)
|
2005-03-21 |
2006-09-28 |
The Walter And Eliza Hall Institute Of Medical Research |
Prophylactic and therapeutic agents and uses therefor
|
|
US20070027175A1
(en)
|
2005-07-27 |
2007-02-01 |
Shaughnessy John Jr |
Antineoplastic activities of ellipticine and its derivatives
|
|
EP2008106A2
(en)
|
2006-03-31 |
2008-12-31 |
Dana-Farber Cancer Institute |
Methods of determining cellular chemosensitivity
|
|
US8518635B2
(en)
|
2006-06-12 |
2013-08-27 |
The J. David Gladstone Institutes |
Regulation of protein activity by reversible acetylation
|
|
KR100786759B1
(ko)
|
2006-07-07 |
2007-12-18 |
김현기 |
Ｈｃｃｒ-1을 포함하는 유방암 예후 마커 및 비만 유도조성물
|
|
WO2008021484A2
(en)
*
|
2006-08-16 |
2008-02-21 |
Eutropics Pharmaceuticals |
Assay system to identify therapeutic agents
|
|
WO2008152405A2
(en)
|
2007-06-15 |
2008-12-18 |
The Queen's University Of Belfast |
Protein complexes comprising bh3 peptides and voltage dependent anion channel (vdac) peptides as well as uses thereof for the treatment of proliferative diseases
|
|
US8466140B2
(en)
|
2007-09-10 |
2013-06-18 |
University Of Massachusetts |
Mitochondria-targeted anti-tumor agents
|
|
JP5783721B2
(ja)
*
|
2007-09-26 |
2015-09-24 |
ダナ ファーバー キャンサー インスティテュート インコーポレイテッド |
Ｂｃｌ−２ファミリーポリペプチドを調節する方法及び組成物
|
|
JP2009240173A
(ja)
|
2008-03-28 |
2009-10-22 |
Univ Of Tokushima |
パーキン蛋白の新規糖化因子
|
|
SG176801A1
(en)
|
2009-06-11 |
2012-01-30 |
Minerva Biotechnologies Corp |
Methods for culturing stem and progenitor cells
|
|
WO2010147961A1
(en)
|
2009-06-15 |
2010-12-23 |
Precision Therapeutics, Inc. |
Methods and markers for predicting responses to chemotherapy
|
|
US20130122492A1
(en)
|
2011-11-14 |
2013-05-16 |
Kellbenx Inc. |
Detection, isolation and analysis of rare cells in biological fluids
|
|
KR102062416B1
(ko)
*
|
2012-05-10 |
2020-01-03 |
유트로픽스 파마슈티컬스, 인크. |
실용 가능한 암 진단 대체 법
|
|
US20150322479A1
(en)
|
2012-06-20 |
2015-11-12 |
Cytospan Technologies Corporation |
Apparatus and method for quantification of replicative lifespan and observation of senescene
|
|
HK1213046A1
(zh)
*
|
2012-09-19 |
2016-06-24 |
Dana-Farber Cancer Institute, Inc. |
動態bh3分析
|
|
JP6327662B2
(ja)
|
2012-09-26 |
2018-05-23 |
学校法人藤田学園 |
細胞表面タンパクを抗原とする抗体を測定する方法
|
|
WO2015010094A1
(en)
*
|
2013-07-18 |
2015-01-22 |
Eutropics Pharmaceuticals, Inc. |
Differential bh3 mitochondrial profiling
|
|
CA2922503C
(en)
|
2013-09-19 |
2021-10-26 |
Dana-Farber Cancer Institute, Inc. |
Methods of bh3 profiling
|
|
AU2016253957C1
(en)
|
2015-04-27 |
2021-04-01 |
Dana-Farber Cancer Institute, Inc. |
High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low numbers of cells
|
|
US11092602B2
(en)
|
2015-07-06 |
2021-08-17 |
Whitehead Institute For Biomedical Research |
Methods and compositions relating to proteasome inhibitor resistance
|
|
JP7589159B2
(ja)
|
2019-02-26 |
2024-11-25 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
ライブセルイメージング（ｌｉｖｅ ｃｅｌｌ ｉｍａｇｉｎｇ）動的ＢＨ３プロファイリング
|